Members NewsPublic News

The position of SGLT2 inhibitors in the treatment pathway for Type 2 Diabetes. Dr Diarmuid Smith, Consultant Endocrinologist, Beaumont

By 13/09/2019No Comments
You need to login to view this content. Please . Not a Member? Join Us

Leave a Reply